Ballew Advisors’s Cigna CI Stock Holding History

Ballew Advisors’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60	Closed	-$10K	–	486
2018 Q2	$10K	Sell	60 -40	-40%	-$6.92K	0.01%	301
2018 Q1	$17K	Buy	+100	New	+$19.4K	0.01%	252

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ballew Advisors's CI Position: Q3 2018 in Review

Ballew Advisors sold out of Cigna (CI) in Q3 2018, closing a stake of 60 shares — an estimated $10K sold.

Ballew Advisors first reported a position in CI in Q1 2018 and held it in 2 quarters. The position peaked at $17K in Q1 2018. 869 funds tracked by Wall St. Rank hold CI as of Q3 2018.

Ballew Advisors reported no remaining Cigna position as of Q3 2018 after selling out during the quarter.
Ballew Advisors sold 60 Cigna shares in Q3 2018, an estimated $10K.
Ballew Advisors first reported a position in Cigna in Q1 2018 and held it in 2 quarters.
Ballew Advisors's Cigna position peaked at $17K in Q1 2018.
869 funds tracked by Wall St. Rank held Cigna as of Q3 2018.

Based on Ballew Advisors's 13F filing for Q3 2018, filed 30 Oct 2018.